Industry's Suits Against Medicare Price Negotiation: Consolidation And Expansion

With a new suit from Boehringer Ingelheim and a consolidated schedule for other cases, the legal threats to the US Medicare drug price negotiation program mandated under the Inflation Reduction Act (IRA) become clearer. Our tracker keeps you apprised of the latest developments.

Expressionist pill and gavel
• Source: Shutterstock

More from Drug Pricing

More from Scrip